Sweet Syndrome Successfully Treated With Ruxolitinib in JAK-2 Positive Myeloproliferative Disorder

doi 10.23937/iaim-2017/1710008

Full Text

Abstract

Available in

Date

Authors

Publisher

ClinMed International Library


Related search